Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Clinical outcomes by albuminuria status with dulaglutide versus insulin glargine in participants with diabetes and CKD: AWARD-7 exploratory analysis
Side effects can include nausea, reduced appetite, and mild injection site reactions
The timeline for peptide results depends on the compound, dose, and protocol, not the reconstitution volume
Include: dose drawn, dose administered, lot number, NDC, residual waste volume, and the modifier to apply
A Randomized, multicenter, open-label, blinded end point, phase 2, feasibility, efficacy, and safety trial of preoperative microvascular protection in patients undergoing major abdominal surgery
US$ 28.13
US$ 27.85
US$ 22.97
US$ 26.30
